TGTX Similar Chart Price Prediction
The price of TGTX is predicted to go up -0.62%, based on the high correlation periods with OPEN. The similarity of these two price pattern on the periods is 93.86%.
TGTX
OPEN
Down: -0.62%Similarity: 93.86%
TGTX Revenue Forecast
TGTX EPS Forecast
TGTX FAQs
What is bull’s view on TGTX?
What is bear's view on TGTX?
What is TGTX revenue forecast for next quarter？
TGTX Analyst's Forecast
Eric Joseph
JP Morgan
Buy
2024-11-25
Price Target
$30 → $43
Upside
+24.24%
JPMorgan raised the firm's price target on TG Therapeutics to $43 from $30 and keeps an Overweight rating on the shares. The firm says that with a potential SC Briumvi formulation coming into view beginning in the first half of 2025, it updated TG's model to reflect risk adjusted Briumvi forecasts within the at-home/self-administered anti-CD20 segment of relapsing multiple sclerosis. At $3.5B, the analyst's peak Briumvi SC forecast assumes market entry beginning in 2028 and ultimately garnering 35% share of the self-administered CD20 segment. JPMorgan sees an increasingly attractive setup to TG shares in the mid-term.
Tara Bancroft
TD Cowen
Strong Buy
2024-10-29
Price Target
$50
Upside
+94.48%
